Oura’s confidential May 2026 S-1 filing following its $900 million Series E round at an $11 billion post-money valuation anchors near-term trader focus, with revenue scaling from roughly $500 million in 2024 toward $1–1.5 billion in 2026 supporting multiple expansion potential. Spread pricing across $10–12.5 billion and $20 billion-plus buckets reflects uncertainty around IPO timing—still subject to SEC review and market conditions—as well as equity-market appetite for high-growth wearables amid broader 2026 IPO pipelines. Key swing factors include sustained subscriber growth, gross-margin trends, and any shifts in comparable multiples for consumer-health tech versus execution risk that could push resolution past January 2027.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日$10B–$12.5B 14%
$20B+ 14%
$15B–$17.5B 13%
$17.5B–$20B 12%
$177,928 Vol.
$177,928 Vol.
2027/01/01
<$7.5B
8%
$7.5B–$10B
11%
$10B–$12.5B
14%
$12.5B–$15B
11%
$15B–$17.5B
13%
$17.5B–$20B
12%
$20B+
14%
No IPO before January 2027
11%
$10B–$12.5B 14%
$20B+ 14%
$15B–$17.5B 13%
$17.5B–$20B 12%
$177,928 Vol.
$177,928 Vol.
2027/01/01
<$7.5B
$19,129 Vol.
8%
$7.5B–$10B
$27,547 Vol.
11%
$10B–$12.5B
$22,365 Vol.
14%
$12.5B–$15B
$50,959 Vol.
11%
$15B–$17.5B
$13,822 Vol.
13%
$17.5B–$20B
$16,938 Vol.
12%
$20B+
$21,689 Vol.
14%
No IPO before January 2027
$5,478 Vol.
11%
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.Oura’s confidential May 2026 S-1 filing following its $900 million Series E round at an $11 billion post-money valuation anchors near-term trader focus, with revenue scaling from roughly $500 million in 2024 toward $1–1.5 billion in 2026 supporting multiple expansion potential. Spread pricing across $10–12.5 billion and $20 billion-plus buckets reflects uncertainty around IPO timing—still subject to SEC review and market conditions—as well as equity-market appetite for high-growth wearables amid broader 2026 IPO pipelines. Key swing factors include sustained subscriber growth, gross-margin trends, and any shifts in comparable multiples for consumer-health tech versus execution risk that could push resolution past January 2027.
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
マーケット開始日： May 26, 2026, 12:28 PM ET
音量
$177,928終了日
2027/01/01マーケット開始日
May 26, 2026, 12:28 PM ETResolver
0x69c47De9D...This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.Oura’s confidential May 2026 S-1 filing following its $900 million Series E round at an $11 billion post-money valuation anchors near-term trader focus, with revenue scaling from roughly $500 million in 2024 toward $1–1.5 billion in 2026 supporting multiple expansion potential. Spread pricing across $10–12.5 billion and $20 billion-plus buckets reflects uncertainty around IPO timing—still subject to SEC review and market conditions—as well as equity-market appetite for high-growth wearables amid broader 2026 IPO pipelines. Key swing factors include sustained subscriber growth, gross-margin trends, and any shifts in comparable multiples for consumer-health tech versus execution risk that could push resolution past January 2027.
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
音量
$177,928終了日
2027/01/01マーケット開始日
May 26, 2026, 12:28 PM ETResolver
0x69c47De9D...Oura’s confidential May 2026 S-1 filing following its $900 million Series E round at an $11 billion post-money valuation anchors near-term trader focus, with revenue scaling from roughly $500 million in 2024 toward $1–1.5 billion in 2026 supporting multiple expansion potential. Spread pricing across $10–12.5 billion and $20 billion-plus buckets reflects uncertainty around IPO timing—still subject to SEC review and market conditions—as well as equity-market appetite for high-growth wearables amid broader 2026 IPO pipelines. Key swing factors include sustained subscriber growth, gross-margin trends, and any shifts in comparable multiples for consumer-health tech versus execution risk that could push resolution past January 2027.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問